Zoetis Inc
XETRA:ZOE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zoetis Inc
XETRA:ZOE
|
US |
|
N
|
Nanjing CIGU Technology Corp Ltd
SSE:688448
|
CN |
|
Viva Energy Group Ltd
ASX:VEA
|
AU |
|
Yunfeng Financial Group Ltd
F:MNA1
|
HK |
|
C
|
Chen Full International Co Ltd
TPEX:8383
|
TW |
|
B
|
BWX Technologies Inc
F:4BW
|
US |
Intrinsic Value
Is ZOE undervalued or overvalued?
See the intrinsic value estimate for 
Zoetis Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ZOE looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with ZOE’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Zoetis Does
Zoetis makes medicines, vaccines, diagnostics, and other health products for animals. Its lineup covers pets, livestock, and poultry, so it serves both veterinarians treating dogs and cats and producers who manage animal health in food production.
- Headquarters
- United States of America US
- Employees
- 14 500
- IPO date
- Feb 1, 2013
Zoetis has a wide economic moat
Patents, protected vaccine formulas and required government approvals prevent rivals from simply copying Zoetis’s treatments and selling them cheaply. Its research develops new medicines and improves existing treatments, helping extend protection across its animal-health portfolio.
Read the full moat analysis
Revenue & Expenses Breakdown
Zoetis Inc
Earnings Waterfall
Zoetis Inc
The intrinsic value for Zoetis Inc (ZOE) under the Base Case is hidden EUR.
Compared with the current market price of 71.6 EUR, the stock appears hidden.